Heterogeneous antigen recognition behavior of induced polyspecific antibodies

Biochemical and Biophysical Research Communications

Volumn 398, Issue 2, 2010, Pages 266-271

  Dimitrov, Jordan D ^a,b   Planchais, Cyril ^a,b   Kang, Jonghoon ^c   Pashov, Anastas ^a,b,d   Vassilev, Tchavdar L ^d   Kaveri, Srinivas V ^a,b   Lacroix Desmazes, Sebastien ^a,b  

^a CENTRE DE RECHERCHE DES CORDELIERS   (France)

^b UNIVERSITÉ PARIS DESCARTES   (France)

^c VALDOSTA STATE UNIVERSITY   (United States)

^d BULGARIAN ACADEMY OF SCIENCES   (Bulgaria)

Author keywords

Antigen recognition; Immunoglobulins; Polyspecificity; Redox agents; Thermodynamics

Indexed keywords

IMMUNOGLOBULIN G ANTIBODY;

ANTIGEN RECOGNITION; ARTICLE; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; PRIORITY JOURNAL; QUALITATIVE ANALYSIS; QUANTITATIVE ANALYSIS;

ANTIBODIES; ANTIGEN-ANTIBODY REACTIONS; ANTIGENS; HUMANS; IMMUNOGLOBULINS, INTRAVENOUS; KINETICS; THERMODYNAMICS;

ANIMALIA;

EID: 77955055848     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2010.06.073     Document Type: Article

References (26)

1. Coutinho A., Kazatchkine M.D., Avrameas S. Natural autoantibodies. Curr. Opin. Immunol. 1995, 7:812-818.
2. Notkins A.L. Polyreactivity of antibody molecules. Trends Immunol. 2004, 25:174-179.
3. James L.C., Roversi P., Tawfik D.S. Antibody multispecificity mediated by conformational diversity. Science 2003, 299:1362-1367.
4. Bouvet J.P., Stahl D., Rose S., et al. Induction of natural autoantibody activity following treatment of human immunoglobulin with dissociating agents. J. Autoimmun. 2001, 16:163-172.
5. Cabiedes J., Cabral A.R., Alarcon-Segovia D. Hidden anti-phospholipid antibodies in normal human sera circulate as immune complexes whose antigen can be removed by heat, acid, hypermolar buffers or phospholipase treatments. Eur. J. Immunol. 1998, 28:2108-2114.
6. McMahon M.J., O'Kennedy R. Polyreactivity as an acquired artefact, rather than a physiologic property, of antibodies: evidence that monoreactive antibodies may gain the ability to bind to multiple antigens after exposure to low pH. J. Immunol. Methods 2000, 241:1-10.
7. Dimitrov J.D., Lacroix-Desmazes S., Kaveri S.V., Vassilev T.L. Transition towards antigen-binding promiscuity of a monospecific antibody. Mol. Immunol. 2007, 44:1854-1863.
8. St-Amour I., Laroche A., Bazin R., Lemieux R. Activation of cryptic IgG reactive with BAFF, amyloid beta peptide and GM-CSF during the industrial fractionation of human plasma into therapeutic intravenous immunoglobulins. Clin. Immunol. 2009, 133:52-60.
9. Djoumerska I., Tchorbanov A., Pashov A., Vassilev T. The autoreactivity of therapeutic intravenous immunoglobulin (IVIG) preparations depends on the fractionation methods used. Scand. J. Immunol. 2005, 61:357-363.
10. Berneman A., Guilbert B., Eschrich S., Avrameas S. IgG auto- and polyreactivities of normal human sera. Mol. Immunol. 1993, 30:1499-1510.
11. Mouthon L., Haury M., Lacroix-Desmazes S., et al. Analysis of the normal human IgG antibody repertoire. Evidence that IgG autoantibodies of healthy adults recognize a limited and conserved set of protein antigens in homologous tissues. J. Immunol. 1995, 154:5769-5778.
12. Bussone G., Dib H., Dimitrov J.D., et al. Identification of target antigens of self-reactive IgG in intravenous immunoglobulin preparations. Proteomics 2009, 9:2253-2262.
13. Bobrovnik S.A. Mechanisms for increasing the activity of polyreactive immunoglobulins in vivo. Ukr. Biokhim. Zh. 1999, 71:129-135.
14. McIntyre J.A. The appearance and disappearance of antiphospholipid autoantibodies subsequent to oxidation-reduction reactions. Thromb. Res. 2004, 114:579-587.
15. Dimitrov J.D., Ivanovska N.D., Lacroix-Desmazes S., et al. Ferrous ions and reactive oxygen species increase antigen-binding and anti-inflammatory activities of immunoglobulin G. J. Biol. Chem. 2006, 281:439-446.
16. Dimitrov J.D., Vassilev T.L., Andre S., et al. Functional variability of antibodies upon oxidative processes. Autoimmun. Rev. 2008, 7:574-578.
17. Omersel J., Jurgec I., Cucnik S., et al. Autoimmune and proinflammatory activity of oxidized immunoglobulins. Autoimmun. Rev. 2008, 7:523-529.
18. Dimitrov J.D., Roumenina L.T., Doltchinkova V.R., et al. Antibodies use heme as a cofactor to extend their pathogen elimination activity and to acquire new effector functions. J. Biol. Chem. 2007, 282:26696-26706.
19. McIntyre J.A., Wagenknecht D.R., Faulk W.P. Redox-reactive autoantibodies: detection and physiological relevance. Autoimmun. Rev. 2006, 5:76-83.
20. Dimitrov J.D., Vassilev T.L. Cofactor-mediated protein promiscuity. Nat. Biotechnol. 2009, 27:892.
21. Hawkins C.L., Pattison D.I., Davies M.J. Hypochlorite-induced oxidation of amino acids, peptides and proteins. Amino Acids 2003, 25:259-274.
22. Fink A.L., Calciano L.J., Goto Y., Kurotsu T., Palleros D.R. Classification of acid denaturation of proteins: intermediates and unfolded states. Biochemistry 1994, 33:12504-12511.
23. Bennion B.J., Daggett V. The molecular basis for the chemical denaturation of proteins by urea. Proc. Natl. Acad. Sci. USA 2003, 100:5142-5147.
24. Zimmermann J., Oakman E.L., Thorpe I.F., Shi X., Abbyad P., Brooks C.L., Boxer S.G., Romesberg F.E. Antibody evolution constrains conformational heterogeneity by tailoring protein dynamics. Proc. Natl. Acad. Sci. USA 2006, 103:13722-13727.
25. Manivel V., Sahoo N.C., Salunke D.M., Rao K.V. Maturation of an antibody response is governed by modulations in flexibility of the antigen-combining site. Immunity 2000, 13:611-620.
26. Kazatchkine M.D., Kaveri S.V. Immunomodulation of autoimmune and inflammatory diseases with intravenous immune globulin. N. Engl. J. Med. 2001, 345:747-755.